These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 28901254)

  • 1. Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future.
    Ghosh S; Malik YS; Kobayashi N
    Curr Drug Metab; 2018; 19(3):170-191. PubMed ID: 28901254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis.
    Blazevic V; Lappalainen S; Nurminen K; Huhti L; Vesikari T
    Vaccine; 2011 Oct; 29(45):8126-33. PubMed ID: 21854823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
    Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V
    Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Recombinant Rotaviruses Expressing Human Norovirus Capsid Proteins.
    Philip AA; Patton JT
    J Virol; 2022 Nov; 96(22):e0126222. PubMed ID: 36314817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral gastroenteritis.
    Bányai K; Estes MK; Martella V; Parashar UD
    Lancet; 2018 Jul; 392(10142):175-186. PubMed ID: 30025810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taking gastro-surveillance into the 21st century.
    Fischer TK; Rasmussen LD; Fonager J
    J Clin Virol; 2019 Aug; 117():43-48. PubMed ID: 31176211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus.
    Tan M; Jiang X
    Nanomedicine (Lond); 2012 Jun; 7(6):889-97. PubMed ID: 22734641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae.
    O'Ryan M; Vidal R; del Canto F; Salazar JC; Montero D
    Hum Vaccin Immunother; 2015; 11(3):584-600. PubMed ID: 25715048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Noroviruses: leading cause of gastroenteritis].
    Delacour H; Dubrous P; Koeck JL
    Med Trop (Mars); 2010 Apr; 70(2):111-8. PubMed ID: 20486340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control and prevention of viral gastroenteritis.
    Monroe SS
    Emerg Infect Dis; 2011 Aug; 17(8):1347-8. PubMed ID: 21801608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of vaccine research and development for norovirus.
    Riddle MS; Walker RI
    Vaccine; 2016 Jun; 34(26):2895-2899. PubMed ID: 27036510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotavirus vaccines: development and use for the prevention of diarrhoeal disease.
    Vesikari T
    Ann Med; 1999 Feb; 31(1):79-85. PubMed ID: 10219717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009-2010.
    Puustinen L; Blazevic V; Salminen M; Hämäläinen M; Räsänen S; Vesikari T
    Scand J Infect Dis; 2011 Oct; 43(10):804-8. PubMed ID: 21696253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rotaviruses "target" infants, noroviruses for seniors].
    Kinderkrankenschwester; 2008 Aug; 27(8):342. PubMed ID: 18757038
    [No Abstract]   [Full Text] [Related]  

  • 15. Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice.
    Tamminen K; Lappalainen S; Huhti L; Vesikari T; Blazevic V
    PLoS One; 2013; 8(7):e70409. PubMed ID: 23922988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developments in understanding acquired immunity and innate susceptibility to norovirus and rotavirus gastroenteritis in children.
    Payne DC; Parashar UD; Lopman BA
    Curr Opin Pediatr; 2015 Feb; 27(1):105-9. PubMed ID: 25490691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in human norovirus research and implications for candidate vaccines.
    Cates JE; Vinjé J; Parashar U; Hall AJ
    Expert Rev Vaccines; 2020 Jun; 19(6):539-548. PubMed ID: 32500763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress on norovirus vaccine research: public health considerations and future directions.
    Mattison CP; Cardemil CV; Hall AJ
    Expert Rev Vaccines; 2018 Sep; 17(9):773-784. PubMed ID: 30092671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe viral gastroenteritis in children after suboptimal rotavirus immunization in Taiwan.
    Chen SY; Tsai CN; Chen CL; Chao HC; Lee YS; Lai MW; Chen CC; Huang WL; Chiu CH
    Pediatr Infect Dis J; 2013 Dec; 32(12):1335-9. PubMed ID: 23881091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norovirus and Rotavirus--two major causative agents of sporadic viral gastroenteritis in hospitalized Polish children.
    Oldak E; Sulik A; Rozkiewicz D; Liwoch-Nienartowicz N; Zawadzka E
    Adv Med Sci; 2009; 54(2):183-6. PubMed ID: 20022857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.